2007 - Fellow of the American Association for the Advancement of Science (AAAS)
1994 - Fellow of John Simon Guggenheim Memorial Foundation
Cell biology, Trk receptor, Neurotrophin, Tropomyosin receptor kinase A and Nerve growth factor are his primary areas of study. His Cell biology study integrates concerns from other disciplines, such as Downregulation and upregulation, Biochemistry, Platelet-derived growth factor receptor and Oligodendrocyte. Moses V. Chao has included themes like Epidermal growth factor, Tropomyosin receptor kinase C, Tyrosine kinase, Signal transduction and Receptor complex in his Trk receptor study.
His research integrates issues of Endocrinology, Neuroscience and Tropomyosin receptor kinase B in his study of Neurotrophin. His biological study spans a wide range of topics, including Neurotrophic factors and Growth factor receptor. The various areas that Moses V. Chao examines in his Receptor study include Molecular biology and Binding site.
The scientist’s investigation covers issues in Cell biology, Neurotrophin, Neuroscience, Receptor and Molecular biology. His Cell biology study combines topics in areas such as Biochemistry and Growth factor. His Neurotrophin research includes elements of Tropomyosin receptor kinase B and Nervous system.
Moses V. Chao combines subjects such as Brain-derived neurotrophic factor, Neurotrophic factors and Synaptic plasticity with his study of Neuroscience. His Receptor research is classified as research in Internal medicine. His Trk receptor study which covers Receptor tyrosine kinase that intersects with ROR1.
Moses V. Chao focuses on Neuroscience, Brain-derived neurotrophic factor, Neurotrophic factors, Neurotrophin and Cell biology. Within one scientific family, he focuses on topics pertaining to Synaptic plasticity under Neuroscience, and may sometimes address concerns connected to Nervous system. His Brain-derived neurotrophic factor study combines topics from a wide range of disciplines, such as Hippocampal formation, Endocrinology and Tropomyosin receptor kinase B.
Moses V. Chao interconnects Tropomyosin receptor kinase C and Trk receptor in the investigation of issues within Tropomyosin receptor kinase B. His research investigates the connection between Neurotrophin and topics such as Nerve growth factor that intersect with problems in Programmed cell death. His research in Cell biology intersects with topics in Virus latency, Receptor, Low-affinity nerve growth factor receptor and Molecular biology.
His main research concerns Neuroscience, Brain-derived neurotrophic factor, Neurotrophic factors, Tropomyosin receptor kinase B and Synaptic plasticity. Moses V. Chao has researched Brain-derived neurotrophic factor in several fields, including Hippocampal formation, Endocrinology and Signal transduction. His studies deal with areas such as Tropomyosin receptor kinase A, Intracellular and Function as well as Signal transduction.
His study in Tropomyosin receptor kinase B is interdisciplinary in nature, drawing from both Neurotrophin, Glucocorticoid receptor and Epidermal growth factor receptor. His Synaptic plasticity research includes themes of Hippocampus and Nerve growth factor. His studies in Receptor integrate themes in fields like Neocortex, Transactivation and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neurotrophins and their receptors: a convergence point for many signalling pathways.
Moses V. Chao.
Nature Reviews Neuroscience (2003)
The trk proto-oncogene product: a signal transducing receptor for nerve growth factor
David R. Kaplan;Barbara L. Hempstead;Dionisio Martin-Zanca;Moses V. Chao.
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition.
Huai-hu Chuang;Elizabeth D. Prescott;Haeyoung Kong;Shannon Shields.
High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor.
Barbara L. Hempstead;Dionisio Martin-Zanca;David R. Kaplan;Luis F. Parada.
TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*
Brian R. Wong;Jaerang Rho;Joseph Arron;Elizabeth Robinson.
Journal of Biological Chemistry (1997)
Expression and structure of the human NGF receptor
Dan Johnson;Anthony Lanahan;C.Randy Buck;Amita Sehgal.
p75 and Trk: A two-receptor system
Moses V. Chao;Barbara L. Hempstead.
Trends in Neurosciences (1995)
Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system.
Kuo-Fen Lee;En Li;L.Julie Huber;Story C. Landis.
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
Alan H Nagahara;David A Merrill;Giovanni Coppola;Shingo Tsukada.
Nature Medicine (2009)
Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75
Patrizia Casaccia-Bonnefil;Bruce D. Carter;Rick T. Dobrowsky;Moses V. Chao.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: